06/05/14: PHARMAQ AS expands its global product portfolio in the aquatic health segment

By signing a distribution agreement with the German Leiber GmbH, PHARMAQ AS teams up with a very competent partner in the interesting segment of yeast products and immune stimulation for its global aquaculture customer base.

"PHARMAQ is very happy to add the quality products from Leiber GmbH to its portfolio. It will make a basis for early entry into new geographies and species, as well as strengthening the relationship with customers in our present markets," says Jan Oppen Berntsen, Director Feed Products and Equipment in PHARMAQ AS.

For 60 years, Leiber GmbH, located in Bramsche in Lower Saxony, has been one of the leading manufacturers of specialist yeast products. The natural raw material brewers' yeast is processed using an innovative biotechnological method to form high-quality products which are used in the areas of animal nutrition, food, food supplements and biotechnology.

"Our customers are found in the salmonid, tilapia, pangasius, sea bass/bream as well as the shrimp segments of the global aquaculture industry. By adding a high quality beta-glucan manufactured by Leiber to our PHARMAQ product portfolio, we will support unspecific immunity to products administered by the oral route," says Jan Oppen Berntsen.

PHARMAQ provides environmentally sound, safe and efficacious health products for the global fish farming industry. Besides a range of therapeutic products, the company's core products are fish vaccines with a broad portfolio of 25 different vaccines for various markets.

The Aquaculturists
This blog is maintained by The Aquaculturists staff and is supported by the magazine International Aquafeed which is published by Perendale Publishers Ltd.